Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

671
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
671

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Subcellular and macrostructural immediate responders to airblast traumatic brain injury.

Scientific reports·2026
Same author

Osimertinib-induced cardiotoxicity is driven by HDAC-dependent epigenetic repression and rescued by vorinostat.

Signal transduction and targeted therapy·2026
Same author

Myeloid-derived immunosuppressive PD-1/PD-L1 signaling is essential to maintain adult heart homeostasis.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Remotely accessible optical microscopy education through a wide (and global) lens.

Journal of microscopy·2026
Same author

Neuroglial Response to High-Amplitude, Short-Duration Pressure Transients in Monoculture.

Cell biochemistry and function·2026
Same author

Cardiomyocytes HIPK2 regulates myocardial inflammation and heart function through purinergic signaling.

Cell communication and signaling : CCS·2026

Related Experiment Video

Updated: Nov 20, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.8K

Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After

J Caleb Snider1, Lance A Riley1, Noah T Mallory1

  • 1Department of Biomedical Engineering, Vanderbilt University, Nashville, TN (J.C.S., L.A.R., N.T.M., M.R.B., R.G., A.M.-J., W.D.M.).

Circulation
|January 21, 2021
PubMed
Summary

Inhibiting the serotonin 2B receptor (5-HT2B) after myocardial infarction (MI) reduces harmful cardiac scarring. This improves heart structure, function, and recovery by modulating fibroblast activity.

Keywords:
cardiac fibrosiscollagen remodelingmyocardial infarctionserotonin 2B receptor

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.0K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.0K

Related Experiment Videos

Last Updated: Nov 20, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.8K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.0K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.0K

Area of Science:

  • Cardiovascular Biology
  • Fibrosis Research
  • Pharmacology

Background:

  • Myocardial infarction (MI) triggers a fibrotic response, creating a collagen scar that can impair heart function.
  • Cardiac myofibroblasts are key in scar formation, making them a therapeutic target to limit post-MI fibrosis.
  • Serotonin 2B receptor (5-HT2B) signaling is implicated in cardiopulmonary diseases and may drive scar development after MI.

Purpose of the Study:

  • To investigate the impact of 5-HT2B inhibition on cardiac remodeling and function following MI.
  • To elucidate the role of 5-HT2B in resident cardiac fibroblasts and myofibroblasts in post-MI scar formation.
  • To explore the molecular mechanisms underlying 5-HT2B's influence on fibroblast behavior.

Main Methods:

  • Utilized pharmacological 5-HT2B antagonists to assess outcomes after MI.
  • Employed inducible genetic ablation of 5-HT2B in Tcf21+ (fibroblasts) and Postn+ (myofibroblasts) lineages.
  • Conducted histological analysis, microstructural characterization, and RNA sequencing for in vitro fibroblast studies.

Main Results:

  • 5-HT2B antagonism reduced scar thickness and border zone area, preserving cardiac structure and function.
  • Inhibition led to thinner, more anisotropic collagen fibers, enhancing contractility and reducing tissue stiffness.
  • Genetic ablation of 5-HT2B in both fibroblasts and myofibroblasts mirrored the beneficial effects of pharmacological inhibition.
  • RNA sequencing revealed decreased fibroblast proliferation and migration via altered Dnajb4 expression and Src phosphorylation.

Conclusions:

  • 5-HT2B signaling in cardiac fibroblasts and myofibroblasts promotes excessive scar formation post-MI.
  • Targeting 5-HT2B offers a promising therapeutic strategy to mitigate adverse cardiac remodeling and improve function after myocardial infarction.